Ryvu
Krakow
About Ryvu
Ryvu is a biopharmaceutical company developing small-molecule therapies that address the clinical limitations of current treatments in oncology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $71.6M
- Funding stage: IPO
- Last round: Post-IPO Debt (Mar 2024)
- Ticker: wse:RVU
- Website: ryvu.com
- Phone: 48 12 297 46 90
Industries & Categories
Biotechnology, Health Care, Medical, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/ryvu-110281 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.